Thrombosis UK joined with organizations representing patients, nurses and health experts to call on the European Commission to take into account cancer-related complications as it designs its European Beating Cancer Plan.
It is estimated that up to 20% of patients with cancer experience venous thrombosis (VTE).
There is a fivefold higher annual incidence of thrombosis among cancer patients, with about 1 in 1,000 in the general population and 1 in 200 in cancer patients.
European Cancer Patient Coalition
With support from LEO Pharma
Carried out by Quality Health Limited